Results 171 to 180 of about 10,884 (213)

Progress of estrogen receptor and spliceosome in endometrial carcinoma. [PDF]

Front Endocrinol (Lausanne)
Hong Z, Mo T, Zhou P, Chen J, Li X.
europepmc   +1 more source

CAFs and Endocrine Therapy Resistance in Hormone Receptor-Positive Breast Cancer. [PDF]

Int J Mol Sci
Sofianidi AA, Stafyla VK, Zagouri F.
europepmc   +1 more source

Exploring the anti-aging potential of phytoestrogens: focus on molecular mechanisms and menopausal symptom modulation. [PDF]

Front Nutr
Li Y, Huang F, Qian X, Liu C, Yao Y, Wang Z, Zhu X, Guo Q.   +7 more
europepmc   +1 more source

Serum Nox1 and Gper Levels in Patients With Generalized Anxiety Disorder: A Cross-Sectional Study in Turkiye. [PDF]

Brain Behav
Hurşitoğlu O, Kurutaş EB, Uygur ÖF, Ozturk N, Uygur H, Saglam F, Strawbridge R.   +6 more
europepmc   +1 more source

Endocrine therapy resistance of breast cancer: Important role of G protein-coupled estrogen receptor (GPER) and new therapeutic strategies. [PDF]

Genes Dis
Yu T, He C, Zhang H, Zhu Y, Wang A, Zeng X, Huang Y, Zhong J, Wu X, Shu Y, Shen G, Yu C, Zhou K, Zeb U, Dejenie R, Peng Y, Haydon RC, Luu HH, Reid RR, He TC, Fan J, Li J.   +21 more
europepmc   +1 more source

GPER Function in Breast Cancer: An Overview [PDF]

Frontiers in Endocrinology, 2014
The G-protein-coupled estrogen receptor-1 (GPER, formerly known as GPR30) has attracted increasing interest, considering its ability to mediate estrogenic signaling in different cell types, including the hormone-sensitive tumors like breast cancer. As observed for other GPCR-mediated responses, the activation of the epidermal growth factor receptor is ...
Rosamaria Lappano, Assunta Pisano, Marcello Maggiolini   +2 more
exaly   +4 more sources